Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa

Published:2017-06 Issue:6 Volume:49 Page:782-783
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Dinh Aurélien^ORCID,Wyplosz Benjamin^ORCID,Kernéis Solen,Lebeaux David,Bouchand Frédérique^ORCID,Duran Clara,Béraud Guillaume,Lazaro Pauline,Davido Benjamin,Hénard Sandrine,Canouï Etienne,Ferry Tristan,Wolff Michel

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference5 articles.

1. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens;Bush;Int J Antimicrob Agents,2015

2. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance;Magiorakos;Clin Microbiol Infect,2012

3. Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI);Solomkin;Clin Infect Dis,2015

4. Ceftolozane–tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI);Wagenlehner;Lancet,2015

5. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12);Sader;J Antimicrob Chemother,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections;Antibiotics;2024-01-07

2. Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese;Open Forum Infectious Diseases;2023-08-28

3. Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review;Microorganisms;2023-07-13

4. The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infections;Expert Opinion on Drug Safety;2023-07-03

5. The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies;Expert Review of Anti-infective Therapy;2023-01-19